<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00221780</url>
  </required_header>
  <id_info>
    <org_study_id>9426-01</org_study_id>
    <secondary_id>2001-030</secondary_id>
    <nct_id>NCT00221780</nct_id>
  </id_info>
  <brief_title>Role of Left Ventricular Pacing Site</brief_title>
  <official_title>Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and
      mortality in heart failure patients. However, very few is known about the importance of the
      left ventricular pacing site. We study in a random order 11 different left ventricular pacing
      sites and compare their hemodynamics using pressure-volume catheters. The consequences on the
      surface ECG are also assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background. Cardiac resynchronization therapy has been shown to be effective in reducing
      symptoms and mortality in heart failure patients. However, very few is known about the
      importance of the left ventricular pacing site.

      Design. Single-blind, monocentric, randomized cross-over study comparing 11 left ventricular
      pacing sites in a random order.

      Intervention. Left ventricular DDD pacing on 11 ventricular sites, prior to the implantation.
      At each pacing site, a control hemodynamics will be obtained in AAI pacing at the same pacing
      rate. At each pacing site, 2 AV delays, a short and a long one, will be assessed.

      Eligibility criteria. Patients referred for cardiac resynchronization therapy for heart
      failure

      Outcomes. Hemodynamic measures using pressure-volume catheters.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2003</start_date>
  <completion_date type="Anticipated">December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation in left ventricular dp/dt max</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>pressures and volumes of the left ventricle</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke work</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>surface ECG repolarisation</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">33</enrollment>
  <condition>Heart Failure</condition>
  <condition>Cardiomyopathy, Dilated</condition>
  <condition>Coronary Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>left ventricular pacing</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart failure referred for cardiac resynchronization therapy

          -  NYHA Class III or IV

          -  Informed consent form signed

        Exclusion Criteria:

          -  Hypertension not controlled by treatment

          -  Coronary ischemia not controlled by treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Jaïs, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Perez, Dr</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Jaïs, Dr</last_name>
    <phone>33 (0) 5 57 65 64 71</phone>
    <email>pierre.jais@chu-bordeaux.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Cardiologique du Haut Lévêque, Rythmology department, Pr CLEMENTY, 3rd Floor</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Jaïs, Dr</last_name>
      <phone>33 (0) 5 57 65 64 71</phone>
      <email>pierre.jais@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Jaïs, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>June 28, 2007</last_update_submitted>
  <last_update_submitted_qc>June 28, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2007</last_update_posted>
  <keyword>Heart failure</keyword>
  <keyword>Cardiomyopathy, dilated</keyword>
  <keyword>Coronary disease</keyword>
  <keyword>Cardiac Pacing, Artificial</keyword>
  <keyword>Hemodynamics</keyword>
  <keyword>Randomized Controlled Trials</keyword>
  <keyword>Single-Blind Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

